rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Doxil

Rediff.com  »  News  »   Doxil

  News for Doxil

  • Business

Stocks that shine year after year

Eicher, Sun, Vakrangee, Astral and Wabco are among those beating benchmark indices each year since 2010 and are likely to see strong earnings growth in the next two years as well. The S&P BSE......

IT, pharma rally expected to continue

Notwithstanding a strong run by the S&P BSE Information Technology (up 60 per cent) and S&P BSE Healthcare (up 22 per cent) indices in 2013, most brokerages are still positive on these two sectors......

Strong US growth to boost pharm cos' fortune in FY14

Sun, Lupin and Dr Reddy’s to lead here, with domestic formulations expected to rebound after Sept quarter. After posting a strong 20-plus per cent growth in the March quarter, top Indian......

Sensex falls 91 pts to 1-mth low

Extending losses for the fourth straight day, the BSE benchmark Sensex on Tuesday fell by over 91 points to end at one-month low level of 19,659.82 due to selling in ITC, RIL and ICICI Bank amid......

Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharmaceutical Industries on Tuesday said it has received US health regulator's approval to market generic version of Doxil injection, used in treating ovarian cancer in the American market.......
  Videos for Doxil
doxil video
doxil video
doxil video
doxil video
doxil video
doxil video
doxil video
doxil video
doxil video
  Web results for Doxil
Poll

Revenue is seen climbing 13.1 percent to Rs 4,879 crore in December quarter from Rs 4,312 crore in corresponding quarter of last fiscal. During... ...

http://www.moneycontrol.com/news/result-poll/operating-performance-may-hurt-sun-pharmas-q3-profit-poll_1301726.html
Current State of Application and Future Potential

:Transparency Market Research The use of nanotechnology for developing efficient drug delivery systems has remained a topic of interest for many... ...

http://pressreleaseping.com/scope-nanotechnology-drug-delivery-current-state-application-and-future-potential
Janssen's Yondelis receives US FDA priority review status to tredat patients with advanced soft tissue sarcoma

Janssen Research & Development, LLC (Janssen) announced that the US Food and Drug Administration (FDA) has granted Priority Review for the New Drug... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=86539&sid=2
Onconova Therapeutics Appoints Dr. Steven M. Fruchtman as Chief Medical Officer

NEWTOWN, Pa., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=55864
CytRx reports positive interim results from phase 2 trial of aldoxorubicin to treat Kaposi's sarcoma in HIV-infected patients

CytRx Corporation, a biopharmaceutical research and development company specialising in oncology, announced positive interim results from its... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=86105&sid=2

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z